Evidence map›Paper›PMID 32383331›Full record

ArticleMolecular genetics & genomic medicine2020

Two different genetic etiologies for tuberous sclerosis complex (TSC) in a single family.

Kate Mowrey, Mary Kay Koenig, Charles A Szabo, Joshua Samuels, Shannon Mulligan, Deborah A Pearson, Hope Northrup

Open access · goldAbstract readCase Reports
In one paragraph

Article in Molecular genetics & genomic medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Kate MowreyDepartment of Pediatrics, Division of Medical Genetics, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA.ORCID 0000-0003-0842-357X
Mary Kay KoenigDepartment of Pediatrics, Division of Child and Adolescent Neurology, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA.
Charles A SzaboDepartment of Neurology and South Texas Comprehensive Epilepsy Center, University of Texas Health Science Center at San Antonio, TX, USA.ORCID 0000-0001-6731-3245
Joshua SamuelsDepartment of Pediatrics, Division of Nephrology and Hypertension, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA.ORCID 0000-0001-5682-4701
Shannon MulliganDepartment of Obstetrics, Gynecology and Reproductive Sciences, Division of Genetic Counseling, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA.
Deborah A PearsonDepartment of Psychiatry and Behavioral Sciences, McGovern Medical School at University of Texas Health Science Center at Houston, Houston, TX, USA.
Hope NorthrupDepartment of Pediatrics, Division of Medical Genetics, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA.
The University of Texas Health Science Center · USThe University of Texas Health Science Center at San Antonio · US

Funding

Preventing Epilepsy using Vigabatrin in Infants with Tuberous Sclerosis ComplexU01NS092595 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BEBIN, MARTINA · 2016 to 2020
$7.1M
NINDS NIH HHS U01 NS092595
6 · The paper itself

Abstract

backgroundTuberous sclerosis complex (TSC) is an autosomal dominant genetic condition that involves abnormalities of the skin, hamartomas in the heart, brain, and kidneys, seizures, as well as TSC-associated neuropsychiatric disorders (TAND). About 90%-95% of individuals with TSC will have an identifiable pathogenic variant in either TSC1 or TSC2. We present here two family members with clinical diagnoses of TSC that were later determined to be due to two different genetic etiologies.

methodsA 2-year-old Caucasian female (Patient 1) was born to non-consanguineous healthy parents and was determined to have a clinical diagnosis of TSC at 2 months old. Her paternal great-uncle (Patient 2) was also known to have a clinical diagnosis of TSC. Sequencing and deletion/duplication analysis for TSC1 and TSC2 were performed on both individuals.

resultsMutation analysis revealed that both Patient 1 and Patient 2 had identifiable pathogenic variants in TSC2. Patient 1 had c.4800_4801delTG (p.Cys1600Trpfs*2), while Patient 2 had c.4470_4471delinsTT (p.Glu1490_Lys1491delinsAsp*).

conclusionTo our knowledge, our clinical report is of significance as it is the third kindred to be identified with affected members with two distinct genetic etiologies for TSC. Our case report highlights the importance of incorporating genetic testing into the clinical evaluation for individuals with features suggestive of TSC.

Indexed as

AdultChild, PreschoolFemaleHumansMaleMiddle AgedMutationPedigreeTuberous SclerosisTuberous Sclerosis Complex 1 ProteinTuberous Sclerosis Complex 2 ProteinTSC1 protein, humanTSC2 protein, humanTuberous Sclerosis Complex 1 ProteinTuberous Sclerosis Complex 2 Proteingenetic counselinggenetic testingTSC2tuberous sclerosis complex

Identifiers

PMID32383331
PMCPMC7336739
OpenAlexW3020881718

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.